Cashu | News | GYRE

HomeWatchlistNewsSignalsPicks

DJI

+0.08%

SPX

-0.22%

IXIC

-0.51%

FTSE

-0.20%

N225

-0.22%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Gyre Therapeutics News

Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA (valbenazine) Capsules in Older Adults with Tardive Dyskinesia

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30

Keymed Biosciences annonce les derniers rsultats d'un essai clinique valuant CM336 publis dans le New England Journal of Medicine

Keymed Biosciences gibt die neuesten Ergebnisse der klinischen Studie mit CM336 bekannt, die im New England Journal of Medicine verffentlicht wurden

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases

Feature Image for interests on Biotechnology, Contracts, Health Care & Hospitals, Healthcare from prnewswire.com

Alamar Biosciences, die Alzheimer's Disease Data Initiative und Gates Ventures schlieen sich zu einer globalen Partnerschaft zusammen, um die translationale Forschung auf dem Gebiet der Alzheimer-Krankheit voranzutreiben.

Feature Image for interests on Biotechnology, Computer & Electronics, Health Care & Hospitals, Healthcare from prnewswire.com

Alamar Biosciences, l'Alzheimer's Disease Data Initiative et Gates Ventures unissent leurs forces dans un partenariat mondial pour faire progresser la recherche translationnelle sur la maladie d'Alzheimer

Feature Image for interests on Biotechnology, Computer & Electronics, Health Care & Hospitals, Healthcare from prnewswire.com

Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease.

Feature Image for interests on Biotechnology, Computer & Electronics, Healthcare, Stock from prnewswire.com

Stocks

Health Care

gyre

Gyre Therapeutics

GYRE

-0.25 (-3.00%)

8.08

USD

At close at Jun 20, 20:41 UTC

Latest Cashu News

Gyre Therapeutics Monitors SciBase and Castle Biosciences' Strategic Alliance for Atopic Dermatitis

Gyre Therapeutics: Breakthrough Bispecific Antibody CM336 Shows Promise for Autoimmune Hemolytic Anemia

Gyre Therapeutics Explores Breakthrough Treatment for Autoimmune Hemolytic Anemia with Keymed's CM336